Literature DB >> 10399792

Sicca syndrome in patients with sarcoidosis.

A A Drosos1, P V Voulgari, D N Psychos, N Tsifetaki, M Bai.   

Abstract

Out of 134, 12 sarcoidosis patients with symptoms of mucosal dryness as the first clinical manifestation were identified and compared with 30 consecutive unselected Sjögren's syndrome (SS) patients. Sicca manifestations were similar among the two groups, while parotid gland enlargement (PGE) was more frequently found in sarcoidosis patients (P < 0.05). Patients with sarcoidosis had mainly pulmonary (P < 0.001) and skin involvement (P < 0.05), while SS patients presented more frequently with Raynaud's phenomenon (P < 0.05). Autoantibody profile was more often found in SS patients compared to sarcoidosis (P < 0.0025). The histopathological findings of minor salivary gland biopsy (MSGB) revealed noncaseating granulomas (NCG) in 58% of patients with sarcoidosis, while in SS, MSGB showed focal sialadenitis in the majority of the patients. Transbronchial lung biopsy (TBLB), which was performed in 10 sarcoidosis patients, revealed the presence of NCG in all patients. In patients with sarcoidosis and sicca symptoms as the presenting syndrome, PGE is a useful clinical finding. Searching for pulmonary involvement is a determining factor to differentiate sarcoidosis from SS. The absence of autoantibodies is another useful tool for the diagnosis of sarcoidosis. Finally, MSGB is very helpful to discriminate between sarcoidosis and SS and when MSGB is not specific, then TBLB is valuable to confirm the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399792     DOI: 10.1007/s002960050081

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  9 in total

1.  c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion.

Authors:  Driss Zoukhri; Elizabeth Macari; Sun H Choi; Claire L Kublin
Journal:  J Neurochem       Date:  2005-11-21       Impact factor: 5.372

Review 2.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

Review 3.  Lessons from diseases mimicking Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

4.  [Use of state-of-the-art ultrasound techniques in diagnosing sarcoidosis of the salivary glands (Heerfordt's syndrome)].

Authors:  T Fischer; M Mühler; D Beyersdorff; H Guski; M Bollow; B Hamm; M Werbs; S Filimonow
Journal:  HNO       Date:  2003-03-27       Impact factor: 1.284

5.  Solitary extramedullary plasmacytoma and granulomatous sialadenitis of the parotid gland preceding a B-cell non-Hodgkin's lymphoma.

Authors:  H Gouveris; T Hansen; K Franke
Journal:  Mund Kiefer Gesichtschir       Date:  2006-03

6.  A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation.

Authors:  Driss Zoukhri; Elizabeth Macari; Claire L Kublin
Journal:  Exp Eye Res       Date:  2007-02-04       Impact factor: 3.467

7.  Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.

Authors:  Hema S Aluri; Claire L Kublin; Suharika Thotakura; Helene Armaos; Mahta Samizadeh; Dillon Hawley; William M Thomas; Paul Leavis; Helen P Makarenkova; Driss Zoukhri
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

Review 8.  Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection.

Authors:  Claudio Vitali
Journal:  Arthritis Res Ther       Date:  2011-08-19       Impact factor: 5.156

Review 9.  Recent Advances of Pacemakers in Treatment of Xerostomia: A Systematic Review.

Authors:  Rayapati Srinivasa Rao; Rajesh Akula; Tammineedi S V Satyanarayana; Venkatagiri Indugu
Journal:  J Int Soc Prev Community Dent       Date:  2019-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.